Botulinum toxin type a in the treatment of children with congenital muscular torticollis

This is a retrospective case series describing the use of botulinum toxin type A in the treatment of children with congenital muscular torticollis who fail to progress with conservative management. A total of 27 children with congenital muscular torticollis, 6-18 mos of age, received 30 botulinum toxin type A injections into their sternocleidomastoid or upper trapezius muscle, or both, at a pediatric tertiary care center between 1995 and 2001. Three children received repeat injections. Twenty of 27 children (74%) had improved cervical rotation or head tilt after the injections, and 2 of 27 (7%) experienced transient adverse events, specifically, mild dysphagia and neck weakness. This series suggests that botulinum toxin type A may be a safe and effective treatment option for children with congenital muscular torticollis who are unresponsive to a traditional regimen of physical therapy and a home program. A prospective, randomized controlled trial is necessary to definitively assess the role of botulinum toxin type A in this population.

Medienart:

Artikel

Erscheinungsjahr:

2005

Erschienen:

2005

Enthalten in:

Zur Gesamtaufnahme - volume:84

Enthalten in:

American journal of physical medicine & rehabilitation - 84(2005), 10 vom: 01. Okt., Seite 813-6

Sprache:

Englisch

Beteiligte Personen:

Oleszek, Joyce L [VerfasserIn]
Chang, Nicki [VerfasserIn]
Apkon, Susan D [VerfasserIn]
Wilson, Pamela E [VerfasserIn]

Themen:

Botulinum Toxins, Type A
Comparative Study
EC 3.4.24.69
Journal Article
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 03.11.2005

Date Revised 17.09.2019

published: Print

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM15816590X